Clinical Trials

Phase 2 Active not recruiting

Anal Canal Carcinoma, Anus Neoplasms

NCT01824875 2026-02-25

Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors

144 enrolled 15 charts

Endocrine

Glucagonoma, Insulinoma, Adenoma, Islet Cell, Somatostatinoma, Gastrinoma, Carcinoma, Islet Cell

NCT05040360 2025-12-15

Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors

Phase 2 Recruiting

141 enrolled

Adenoma, Islet Cell

NCT02598349 2025-09-09

Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas

Phase 2 Recruiting

60 enrolled

Pancreatic Neoplasms

NCT02205047 2025-07-31

INNOVATION

172 enrolled

Stomach Neoplasms

NCT02954055 2024-02-26

METEORA-II

140 enrolled 11 charts

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT02560298 2023-06-22

InterAACT

Phase 2 Unknown

91 enrolled

Anal Canal Carcinoma, Anus Neoplasms

NCT02358356 2022-07-05

CONTROL NETS

75 enrolled

Neuroectodermal Tumors, Primitive

NCT04089150 2021-10-22

MASTERPLAN

Phase 2 Unknown

120 enrolled

Pancreatic Neoplasms

NCT00314353 2021-10-06

Study of Bevacizumab Combined With Capecitabine and Either Oxaliplatin or Irinotecan as First Course of Treatment for Patients With Colorectal Cancer That Has Spread Beyond the Colon

7 enrolled 5 charts

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00365417 2021-04-13

Therapy With Bevacizumab (BEV), Doxorubicin, and Cyclophosphamide Followed by BEV, Docetaxel, and Capecitabine Before Surgery Followed by BEV Alone After Surgery for Women With Locally Advanced Breast Cancer

45 enrolled 15 charts

Breast

Breast Neoplasms

NCT00671645 2020-10-19

Preoperative Combined RadioChemo-Molecular Target Therapy With Capecitabine, Bevacizumab, and Radiotherapy

8 enrolled

Carcinoma, Erythema Multiforme, Rectal Neoplasms

NCT00081289 2020-02-27

Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy in Treating Patients Who Are Undergoing Surgical Resection for Locally Advanced Rectal Cancer

146 enrolled 23 charts

Rectal Neoplasms, Colorectal Neoplasms

NCT00613080 2018-09-25

Combination Chemotherapy and Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer

79 enrolled 12 charts

Rectal Neoplasms, Colorectal Neoplasms

NCT01921751 2018-07-13

High or Standard Intensity Radiation Therapy After Gemcitabine Hydrochloride and Nab-paclitaxel in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery

20 enrolled 9 charts

Pancreatic Neoplasms

NCT00686166 2018-05-18

S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal Cancer

83 enrolled 8 charts

Rectal Neoplasms, Colorectal Neoplasms

NCT00789958 2018-04-09

S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct

105 enrolled 13 charts

Bile Duct Neoplasms, Gallbladder Neoplasms

NCT00033540 2017-09-12

S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma

57 enrolled 9 charts

Bile Duct Neoplasms, Gallbladder Neoplasms

NCT00039442 2017-08-24

Capecitabine in Treating Patients With Persistent or Recurrent Cervical Cancer

21 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT01123473 2016-10-12

Epirubicin Hydrochloride, Cisplatin, and Fluorouracil or Capecitabine With or Without Lapatinib Ditosylate as First-Line Therapy in Treating Patients With Stomach Cancer or Gastroesophageal Junction Cancer

29 enrolled

Stomach Neoplasms

NCT00962312 2014-12-31

Lapatinib Ditosylate and Capecitabine in Treating Patients With Metastatic Pancreatic Cancer

9 enrolled

Pancreatic Neoplasms

NCT01434147 2014-03-07

Preoperative Combined Induction Chemotherapy With Capecitabine, Oxaliplatin, Bevacizumab and Radiotherapy

25 enrolled

Rectal Neoplasms

NCT00297141 2013-12-31

Preoperative Combined Radiochemotherapy for Patients With Rectal Carcinoma

60 enrolled

Rectal Neoplasms

NCT00095641 2013-11-08

S0225 Capecitabine in Treating Patients Who Have Undergone Surgery for Locally Recurrent or Persistent Head and Neck Cancer

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT00107276 2013-07-18

S0430 Cyclophosphamide and Capecitabine in Treating Women With Stage IV Breast Cancer

112 enrolled 6 charts

Breast

Breast Neoplasms

NCT00016926 2013-05-27

Capecitabine in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

Gynecologic

Uterine Cervical Neoplasms

NCT00006812 2013-04-11

Capecitabine in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cavity Cancer

Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT01710592 2013-01-10

ELECT

35 enrolled

Gastro Oesophageal Cancer

NCT00049335 2013-01-03

S0030: Capecitabine in Treating Older Patients W/Metastatic or Recurrent Colorectal Cancer That Cannot Be Surgically Removed

29 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00118105 2013-01-03

S0408: Capecitabine, Oxaliplatin, and Bevacizumab in Pts Undergoing Surgery for Liver Mets From Colorectal Cancer

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

NCT00058318 2012-11-02

S0312, Gemcitabine and Capecitabine in Treating Patients With Advanced Renal Cell (Kidney) Cancer

43 enrolled

Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00335959 2012-08-17

S0425 Oxaliplatin, Capecitabine, and RT in Treating Patients W/Stomach Cancer That Can Be Removed By Surgery

7 enrolled 7 charts

Stomach Neoplasms

NCT00070434 2012-06-07

S0304 Induct Chemo Then Chemo-RT in Pts w/Locally Advanced Adenocarcinoma of the Rectum

Rectal Neoplasms, Colorectal Neoplasms

NCT00297128 2011-12-30

Preoperative Chemoradiation With Capecitabine and Cetuximab

31 enrolled

Neoplasms, Rectal Neoplasms

NCT00346099 2008-01-07

Study of Panitumumab Given First With Capecitabine and Oxaliplatin (CAPOX) and Then With Capecitabine and Radiation of the Pelvis for Treatment of Patients With Rectal Cancers That May or May Not Have Spread Beyond the Rectum